Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-045806

Director acquired 220 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anderson Kenneth Carl Director 2021-07-02 Grant or award +220 $39.72 $8,738 85,366 D
Loading xslF345X03/doc4.xml…